(2R,3S,4R,5R)-2-(hydroxyMethyl)-5-(6-((2-(Methylthio)ethyl)aMino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-3,4-diol

Published date: 2017-06-13 19:35:46

Name	(2R,3S,4R,5R)-2-(hydroxyMethyl)-5-(6-((2-(Methylthio)ethyl)aMino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-3,4-diol	CAS#	163706-58-9
Price	￥Inquiry/1kg	Purity	98.0%
Stocking Period	Inquiry	Stock	Inquiry
Product Webpage:	http://www.chemkey-pharma.com/

Detail Product Information Chemical & Physical Properties: CAS Number: 163706-58-9 Name: (2R,3S,4R,5R)-2-(hydroxyMethyl)-5-(6-((2-(Methylthio)ethyl)aMino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-3,4-diol Molecular Formula: C16H22F3N5O4S2 Molecular Weight: 469.502 Density: 1.7±0.1 g/cm3 Boiling Point: 747.5±70.0 °C at 760 mmHg Melting Point: N/A Flash Point: 405.9±35.7 °C

Jinan Chemkey Pharmaceutical Co., Ltd.

Chemsrc Level: Unverified
Tel: +86531-88255618
Address: International Building 2, Lixia District of Jinan, Shandong Province , China
Area: China
Contact: wang
Contact Phone #: +86-13964026275
Email: chemkey@126.com
Website: http://www.chemkey-pharma.com/
Annual Trade Volume:
Foreign Trade % of Sales:
Major partners:

Jinan chemkey pharmaceutical Co., Ltd. is a research,production,sales focus on pharmaceutical intermediates,drugs,APIs and new drug impurity reference. Company as foreign pharmaceutical enterprises OEM production, accumulation of foreign company management experience and production technology of large, mature technology, stable quality, consistent with the United States, Iran and other countries Pharmacopoeia, company of production and quality management of pharmaceutical intermediates in accordance with CGMP.Has a clear competitive advantage in the pharmaceutical and chemical industry. Products sold in China each big pharmaceutical companies, exported to India, Iran, Korea, Italy and other countries.
The company adheres the concept of scientific and technological innovation, we possess modern pilot bases to meet production needing of different sizes.R&D strength, and have reached a strategic cooperation of Shandong University, China Medicine University, Shandong Polytechnic university, China Agricultural university, Shandong Academy of Medical Sciences, Shandong Academy of Sciences, Chinese Academy of Sciences, Shanghai Institute of organic chemistry, AstraZeneca R&D Center and other research institutes. R&D team doctor in the United States 2, 6 professors,18 master's degree, and bachelor degree or above accounted for the company staff ratio of 80%.The main organization of the company are: 2 production plants, R& D center, and Jinan sales center.
The future depends on the health of people, and it is innovation that establishes a good brand. The company is committed to the use of advanced technology and management philosophy, to create a high efficiency and high quality integrated medical service platform. We aim at the high-quality and high-tech pharmaceutical product, take the customer as our life, and achieve our own value by serving the society. Chemkey pharm will take continuous efforts to serve the great cause of human health with more and more new and high quality medicines.

2024-07-15	(2R,3S,4R,5R)-2-(hydroxyMethyl)-5-(6-((2-(Methylthio)ethyl)aMino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-3,4-diol Price: Inquiry
2021-07-26	(2R,3S,4R,5R)-2-(hydroxyMethyl)-5-(6-((2-(Methylthio)ethyl)amino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-3,4-diol Price: $Inquiry
2024-01-09	N6-(2-methylthioethyl)-2-(3,3,3-trifluoropropylthio)adenosine Price: $Inquiry